Rondo Therapeutics Announces Collaboration With Lilly to Develop Novel Cd28 Bispecific Antibodies for Solid Tumors
Rondo Therapeutics宣佈與Lilly合作,開發用於實體腫瘤的新型Cd28雙特異性抗體
Rondo Therapeutics Announces Collaboration With Lilly to Develop Novel Cd28 Bispecific Antibodies for Solid Tumors
Rondo Therapeutics宣佈與Lilly合作,開發用於實體腫瘤的新型Cd28雙特異性抗體
使用瀏覽器的分享功能,分享給你的好友吧